Juliana Siqueira Chaves
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Juliana Siqueira Chaves has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Fernando Batista Da Costa
Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil
3 shared publications - Joao Batista Calixto
Departamento de Farmacologia, Centro de Ciências Biológicas, Universidade Federal de Santa Catarina, Florianópolis, SC, Brazil
3 shared publications - Adair Roberto Soares Santos
Post-Graduate Program in Neuroscience, Center of Biological Sciences, Federal University of Santa Catarina, Florianopolis 88040-535, SC, Brazil
1 shared publication Adriana Pereira Soares
1 shared publication- Alexandre de Paula Rogério
Institute of Health Sciences, Department of Clinical Medicine, Laboratory of Experimental Immunopharmacology, Federal University of Triangulo Mineiro, Uberaba, MG, Brazil
1 shared publication Ana Paula Luiz
1 shared publication
Latest Publications
- 1 April 2010
- Published by Elsevier in Pharmacological Research
- Vol. 61 (4) , 288-297
Anti-inflammatory effect of quercetin-loaded microemulsion in the airways allergic inflammatory model in mice
- 1 April 2010
- Published by Elsevier in Pharmacological Research
- Vol. 61 (4) , 288-297
Anti-inflammatory effect of quercetin-loaded microemulsion in the airways allergic inflammatory model in mice
- Open Access
- 1 September 2009
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Pharmaceutical Sciences
- Vol. 45 (3) , 573-584
Development of enteric coated tablets from spray dried extract of feverfew (Tanacetum parthenium L: )
Tanacetum parthenium (feverfew) is an herb that is commercialized worldwide as a therapeutic treatment for migraine. Its pharmacological effect is mainly due to the presence of the sesquiterpene lactone parthenolide as well as of flavonoids. So far, there are no studies on standardization of pre-formulations or phytomedicines containing this herb. The present study aimed at developing a pre-formulation using a standardized spray-dried extract of feverfew and further designing and standardizing enteric coated tablets. In this work, the spray-dried extract of feverfew was evaluated for its parthenolide, santin and total flavonoid content, parthenolide solubility, particle size, tapped density, hygroscopicity, angle of repose and moisture content. Tablets containing the spray-dried extract were tested for their average weight, friability, hardness, and disintegration time. The total flavonoid and parthenolide contents in the spray-dried extract were 1.31 % and 0.76% w/w, respectively. The spray-dried extract presented consistent pharmacotechnical properties and allowed its tableting by direct compression. Tablet properties were in accordance with the proposed specifications. The procedures described herein can be used to prepare and evaluate pre-formulations of feverfew with adequate properties for the development of a high-quality phytomedicine.
- 1 September 2009
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Pharmaceutical Sciences
- Vol. 45 (3) , 573-584
Open AccessDevelopment of enteric coated tablets from spray dried extract of feverfew (Tanacetum parthenium L: )
Tanacetum parthenium (feverfew) is an herb that is commercialized worldwide as a therapeutic treatment for migraine. Its pharmacological effect is mainly due to the presence of the sesquiterpene lactone parthenolide as well as of flavonoids. So far, there are no studies on standardization of pre-formulations or phytomedicines containing this herb. The present study aimed at developing a pre-formulation using a standardized spray-dried extract of feverfew and further designing and standardizing enteric coated tablets. In this work, the spray-dried extract of feverfew was evaluated for its parthenolide, santin and total flavonoid content, parthenolide solubility, particle size, tapped density, hygroscopicity, angle of repose and moisture content. Tablets containing the spray-dried extract were tested for their average weight, friability, hardness, and disintegration time. The total flavonoid and parthenolide contents in the spray-dried extract were 1.31 % and 0.76% w/w, respectively. The spray-dried extract presented consistent pharmacotechnical properties and allowed its tableting by direct compression. Tablet properties were in accordance with the proposed specifications. The procedures described herein can be used to prepare and evaluate pre-formulations of feverfew with adequate properties for the development of a high-quality phytomedicine.
- 1 July 2009
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 93 (1) , 10-16
Mechanisms involved in the antinociception caused by ethanolic extract obtained from the leaves of Melissa officinalis (lemon balm) in mice
- 1 July 2009
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 93 (1) , 10-16
Mechanisms involved in the antinociception caused by ethanolic extract obtained from the leaves of Melissa officinalis (lemon balm) in mice
- 24 October 2008
- Published by Georg Thieme Verlag KG in Planta Medica
- Vol. 74 (14) , 1678-1683
Pharmacokinetics and Tissue Distribution of the Sesquiterpene α-Humulene in Mice
A quantitative study was undertaken to assess the plasma and tissue levels, tissue distribution and skin (ear) absorption of the sesquiterpene α-humulene, the main active constituent isolated from the plant Cordia verbenacea (Boraginaceae), after oral, intravenous and topical administration in mice. The α-humulene levels were quantified by GC-MS analysis. The peak α-humulene concentration was achieved 15 min following its oral administration (150 mg/kg). Then, the α-humulene plasma concentration gradually decreased and it was almost undetectable at 2 hours after intravenous administration and 12 hours after oral administration. When the oil of C. verbenacea was given orally (1 g/kg), the peak α-humulene plasma concentration was observed after 30 min, being detectable only up to 2 h. The oral bioavailability of α-humulene was found to be 18 %. The half-lives of α-humulene were very short, 16.8 min after oral administration and 1.8 min after intravenous administration. However, the elimination half-lives were longer, 118.2 min and 55 min, for oral and intravenous routes, respectively. We also assessed the amount of α-humulene in some selected tissues at 0.5 and at 4 h after oral administration. We found a high amount of the compound in the liver, followed by the kidneys, heart, lungs, spleen and brain, 0.5 h after oral administration. Notably, the yield of α-humulene decreased significantly in all analyzed tissues, especially in the liver, 4 h after oral administration. Of note, 30 minutes after topical administration of Acheflan® formulations (cream and aerosol) containing 0.5 % of C. verbenacea essential oil, a schedule of treatment that produces marked and similar topical anti-inflammatory activity, the amount of α-humulene absorbed in the ear was very similar (about 2 μg/ear). It is concluded that α-humulene exhibited a rapid onset and relatively good absorption following oral and topical administration. Taken together, these findings further contribute to an explanation of the topical and systemic anti-inflammatory and antinociceptive properties previously reported for the essential oil and for α-humulene obtained from Cordia verbenacea, they also provide support for the clinical studies conducted with the phytomedicine Acheflan®. AUC:area under the plasma level/time curve Cmax:maximum peak concentration GC-MS:gas chromatography/mass spectrometry Tmax:time to achieve Cmax Tœ:half-life Tœ a:half-life of absorption Tœ b:half-life of elimination
- 24 October 2008
- Published by Georg Thieme Verlag KG in Planta Medica
- Vol. 74 (14) , 1678-1683
Pharmacokinetics and Tissue Distribution of the Sesquiterpene α-Humulene in Mice
A quantitative study was undertaken to assess the plasma and tissue levels, tissue distribution and skin (ear) absorption of the sesquiterpene α-humulene, the main active constituent isolated from the plant Cordia verbenacea (Boraginaceae), after oral, intravenous and topical administration in mice. The α-humulene levels were quantified by GC-MS analysis. The peak α-humulene concentration was achieved 15 min following its oral administration (150 mg/kg). Then, the α-humulene plasma concentration gradually decreased and it was almost undetectable at 2 hours after intravenous administration and 12 hours after oral administration. When the oil of C. verbenacea was given orally (1 g/kg), the peak α-humulene plasma concentration was observed after 30 min, being detectable only up to 2 h. The oral bioavailability of α-humulene was found to be 18 %. The half-lives of α-humulene were very short, 16.8 min after oral administration and 1.8 min after intravenous administration. However, the elimination half-lives were longer, 118.2 min and 55 min, for oral and intravenous routes, respectively. We also assessed the amount of α-humulene in some selected tissues at 0.5 and at 4 h after oral administration. We found a high amount of the compound in the liver, followed by the kidneys, heart, lungs, spleen and brain, 0.5 h after oral administration. Notably, the yield of α-humulene decreased significantly in all analyzed tissues, especially in the liver, 4 h after oral administration. Of note, 30 minutes after topical administration of Acheflan® formulations (cream and aerosol) containing 0.5 % of C. verbenacea essential oil, a schedule of treatment that produces marked and similar topical anti-inflammatory activity, the amount of α-humulene absorbed in the ear was very similar (about 2 μg/ear). It is concluded that α-humulene exhibited a rapid onset and relatively good absorption following oral and topical administration. Taken together, these findings further contribute to an explanation of the topical and systemic anti-inflammatory and antinociceptive properties previously reported for the essential oil and for α-humulene obtained from Cordia verbenacea, they also provide support for the clinical studies conducted with the phytomedicine Acheflan®. AUC:area under the plasma level/time curve Cmax:maximum peak concentration GC-MS:gas chromatography/mass spectrometry Tmax:time to achieve Cmax Tœ:half-life Tœ a:half-life of absorption Tœ b:half-life of elimination
- Open Access
- 1 September 2008
- Published by Springer Nature in Revista Brasileira de Farmacognosia
- Vol. 18 (3) , 360-366
A proposal for the quality control of Tanacetum parthenium (feverfew) and its hydroalcoholic extract
- 1 September 2008
- Published by Springer Nature in Revista Brasileira de Farmacognosia
- Vol. 18 (3) , 360-366
Open AccessA proposal for the quality control of Tanacetum parthenium (feverfew) and its hydroalcoholic extract
- 1 July 2008
- Published by Elsevier in Phytochemistry
- Vol. 69 (10) , 2052-2060
Constituents of glandular trichomes of Tithonia diversifolia: Relationships to herbivory and antifeedant activity
- 1 July 2008
- Published by Elsevier in Phytochemistry
- Vol. 69 (10) , 2052-2060
Constituents of glandular trichomes of Tithonia diversifolia: Relationships to herbivory and antifeedant activity
- 1 January 2007
- Published by Taylor & Francis in Pharmaceutical Biology
- Vol. 45 (10) , 749-752
Screening of Southeastern BrazilianMikania. Species onTrypanosoma cruzi.
- 1 January 2007
- Published by Taylor & Francis in Pharmaceutical Biology
- Vol. 45 (10) , 749-752
Screening of Southeastern BrazilianMikania. Species onTrypanosoma cruzi.
- Open Access
- 1 October 2003
- Published by Sociedade Brasileira de Quimica (SBQ) in Journal of the Brazilian Chemical Society
- Vol. 14 (5) , 734-737
Sesquiterpene lactones and other chemical constituents of Mikania hoehnei R.
C NMR and MS spectroscopic analyses and comparisons with previously reported data were used for the identification of these compounds.
- 1 October 2003
- Published by Sociedade Brasileira de Quimica (SBQ) in Journal of the Brazilian Chemical Society
- Vol. 14 (5) , 734-737
Open AccessSesquiterpene lactones and other chemical constituents of Mikania hoehnei R.
C NMR and MS spectroscopic analyses and comparisons with previously reported data were used for the identification of these compounds.